Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
A
|
Avantel Ltd
BSE:532406
|
IN |
|
Benesse Holdings Inc
TSE:9783
|
JP |
|
W
|
Weichai Power Co Ltd
OTC:WEICF
|
CN |
|
S
|
SPG Co Ltd
KOSDAQ:058610
|
KR |
|
L
|
Loblaw Companies Ltd
OTC:LBLCF
|
CA |
|
S
|
Synergy Grid and Development Phils Inc
XPHS:SGP
|
PH |
|
Maxim Power Corp
TSX:MXG
|
CA |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for IOVA is 8.84 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
8.84
USD
According to Wall Street analysts, the average 1-year price target for IOVA is 8.84 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
39%
The compound annual growth rate for Revenue over the next 3 years is 39%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
71%
The compound annual growth rate for Gross Profit over the next 3 years is 71%.
